Mid-Cap

Revolutionary Treatments on the Horizon with CRB-701 and CRB-913 Corbus Pharmaceutical (CRPB), an early-stage clinical biotechnology company, is making significant...

Anticipated Growth in XDEMVY Sales, Sales Force Expansion, and Promising Pipeline Signal a Bright Future for TARS Pharmaceuticals As we...

Obesity Drug VK2735 to Enter Phase 3, NASH Therapy VK2809 Shows Promising Results, and Novel Treatments in Development Viking Therapeutics...

Financial Performance and Strategic Investments Shape a Promising Future Cleveland-Cliffs (CLF) has announced its second-quarter results for the period ending...

Understanding Market Dynamics and Strategic Investment Picks in the Face of Geopolitical Uncertainty The semiconductor industry has long been a...

Undermonetized but Promising: Rumble’s Future in Social Video and Cloud Services Rumble (RUM), a burgeoning social video platform and cloud...

Navigating the Future of Rivian with VW Partnership and Strategic Shifts Morgan Stanley's (MS) latest note on Rivian (RIVN) outlines...

Exploring New Frontiers in Effective Weight Management Obesity continues to be a pressing global health issue, necessitating the continual evolution...

Anthony Noto, CEO of SoFi, appeared on CNBC to discuss the company's trajectory, recent achievements, and strategic vision Early this...

First Patient Dosed in Phase 2 Trial CALC has reached a significant milestone in its journey to address severe acute...